Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anemija, sirupo ląstelė - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

baxter lithuania, uab - ciklofosfamidas - dengtos tabletės - 50 mg; 1000 mg; 200 mg; 500 mg - cyclophosphamide

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - kiti nervų sistemos vaistai - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - virškinimo trakto stromos navikai - antinavikiniai vaistai - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg - cyclophosphamide

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

limedika, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg; 200 mg; 500 mg - cyclophosphamide

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

limedika, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 1000 mg - cyclophosphamide

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

limedika, uab - ciklofosfamidas - dengtos tabletės - 50 mg - cyclophosphamide

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - ciklofosfamidas - milteliai injekciniam tirpalui - 500 mg - cyclophosphamide

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologai - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.